Erratum: TWEAK and RIPK1 mediate a second wave of cell death during AKI (Proceedings of the National Academy of Sciences of the United States of America (2018) 115 (4182-4187) DOI: 10.1073/pnas.1716578115);TWEAK and RIPK1 mediate a second wave of cell death during AKI

Proceedings of the National Academy of Sciences of the United States of America

Volumn 115, Issue 16, 2018, Pages 4182-4187

  Martin Sanchez, Diego ^a   Fontecha Barriuso, Miguel ^a   Carrasco, Susana ^a   Sanchez Niño, Maria Dolores ^a   Von Mässenhausen, Anne ^b   Linkermann, Andreas ^b   Cannata Ortiz, Pablo ^c   Ruiz Ortega, Marta ^a,d   Egido, Jesus ^a,c   Ortiz, Alberto ^a,c   Sanz, Ana Belen ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

Author keywords

AKI; Cell death; Fn14; RIPK1; TWEAK

Indexed keywords

CASPASE 8; MIXED LINEAGE KINASE; MIXED LINEAGE LIKE PROTEIN; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE 1; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE 3; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 12; UNCLASSIFIED DRUG; FOLIC ACID; IMIDAZOLE DERIVATIVE; INDOLE DERIVATIVE; NECROSTATIN-1; RIPK1 PROTEIN, MOUSE; RIPK3 PROTEIN, MOUSE; TNFRSF12A PROTEIN, MOUSE; TNFSF12 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 12A;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FERROPTOSIS; GENETIC DISORDER; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY INJURY; MOUSE; NECROPTOSIS; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; CHEMICALLY INDUCED; CYTOLOGY; DEFICIENCY; DRUG EFFECT; GENETICS; INFLAMMATION; KIDNEY PROXIMAL TUBULE; NECROSIS; PATHOLOGY; PHYSIOLOGY; TUMOR MICROENVIRONMENT;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; CELL LINE; CELLULAR MICROENVIRONMENT; CYTOKINE TWEAK; ENZYME ACTIVATION; FEMALE; FOLIC ACID; IMIDAZOLES; INDOLES; INFLAMMATION; KIDNEY TUBULES, PROXIMAL; MICE; MICE, INBRED C57BL; NECROSIS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; TWEAK RECEPTOR;

EID: 85045529681     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1806694115     Document Type: Erratum

References (33)

1. Siew ED, et al. (2015) Predictors of recurrent AKI. J Am Soc Nephrol 27:1190–1200.
2. Bellomo R, Kellum JA, Ronco C (2012) Acute kidney injury. Lancet 380:756–766.
3. Linkermann A, Stockwell BR, Krautwald S, Anders HJ (2014) Regulated cell death and inflammation: An auto-amplification loop causes organ failure. Nat Rev Immunol 14: 759–767.
4. Linkermann A, et al. (2013) Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc Natl Acad Sci USA 110:12024–12029.
5. Martin-Sanchez D, et al. (2017) Ferroptosis, but not necroptosis, is important in nephrotoxic folic acid-induced AKI. J Am Soc Nephrol 28:218–229.
6. Cho YS, et al. (2009) Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137:1112–1123.
7. Wu XN, et al. (2014) Distinct roles of RIP1-RIP3 hetero- and RIP3-RIP3 homo-interaction in mediating necroptosis. Cell Death Differ 21:1709–1720.
8. Sun L, et al. (2012) Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148:213–227.
9. Mulay SR, Linkermann A, Anders HJ (2015) Necroinflammation in kidney disease. J Am Soc Nephrol 27:27–39.
10. Xu Y, et al. (2015) A role for tubular necroptosis in cisplatin-induced AKI. J Am Soc Nephrol 26:2647–2658.
11. Tristão VR, et al. (2016) Synergistic effect of apoptosis and necroptosis inhibitors in cisplatin-induced nephrotoxicity. Apoptosis 21:51–59.
12. Sanz AB, et al. (2014) TWEAK and the progression of renal disease: Clinical translation. Nephrol Dial Transplant 29(Suppl 1):i54–i62.
13. Sanz AB, et al. (2008) The cytokine TWEAK modulates renal tubulointerstitial inflammation. J Am Soc Nephrol 19:695–703.
14. Hotta K, et al. (2011) Direct targeting of fibroblast growth factor-inducible 14 protein protects against renal ischemia reperfusion injury. Kidney Int 79:179–188.
15. Xia Y, et al. (2014) Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis. J Am Soc Nephrol 26: 1053–1070.
16. Justo P, et al. (2006) Cytokine cooperation in renal tubular cell injury: The role of TWEAK. Kidney Int 70:1750–1758.
17. Friedmann Angeli JP, et al. (2014) Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol 16:1180–1191.
18. Orozco S, et al. (2014) RIPK1 both positively and negatively regulates RIPK3 oligo-merization and necroptosis. Cell Death Differ 21:1511–1521.
19. Dannappel M, et al. (2014) RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature 513:90–94.
20. Biton S, Ashkenazi A (2011) NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-α feedforward signaling. Cell 145:92–103.
21. Guo X, et al. (2016) TAK1 regulates caspase 8 activation and necroptotic signaling via multiple cell death checkpoints. Cell Death Dis 7:e2381.
22. Lorz C, et al. (2004) Paracetamol-induced renal tubular injury: A role for ER stress. J Am Soc Nephrol 15:380–389.
23. Justo P, Lorz C, Sanz A, Egido J, Ortiz A (2003) Intracellular mechanisms of cyclosporin A-induced tubular cell apoptosis. J Am Soc Nephrol 14:3072–3080.
24. Günther C, et al. (2016) The pseudokinase MLKL mediates programmed hepatocel-lular necrosis independently of RIPK3 during hepatitis. J Clin Invest 126:4346–4360.
25. Martin-Sanchez D, et al. (2018) Targeting of regulated necrosis in kidney disease. Nefrologia 38:125–135.
26. Sanchez-Niño MD, et al. (2010) TNF superfamily: A growing saga of kidney injury modulators. Mediators Inflamm 2010:182958.
27. Linkermann A, Green DR (2014) Necroptosis. N Engl J Med 370:455–465.
28. Dondelinger Y, et al. (2013) RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition. Cell Death Differ 20:1381–1392.
29. Dondelinger Y, et al. (2015) NF-κB-independent role of IKKα/IKKβ in preventing RIPK1 kinase-dependent apoptotic and necroptotic cell death during TNF signaling. Mol Cell 60:63–76.
30. Dillon CP, et al. (2014) RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 157:1189–1202.
31. Kondylis V, Kumari S, Vlantis K, Pasparakis M (2017) The interplay of IKK, NF-κB and RIPK1 signaling in the regulation of cell death, tissue homeostasis and inflammation. Immunol Rev 277:113–127.
32. Metz-Kurschel U, et al. (1990) Folate nephropathy occurring during cytotoxic chemotherapy with high-dose folinic acid and 5-fluorouracil. Ren Fail 12:93–97.
33. Newton K, Sun X, Dixit VM (2004) Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol Cell Biol 24:1464–1469.